CFDE Data Portal | Search LINC02777

	Label	Description
	LINC02777 Gene (Entity type)	ENSG00000232453 - long intergenic non-protein coding RNA 2777
	GSE144843 GSE144844 SMARCA2 SMARCA4 knockdown 5 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 menadione 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 4 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE89484 GSE89669 demethylase inhibition Novikoff-Hepatoma 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE184892 trehalose fibroblast 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE112202 digoxin 4 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02777

ENSG00000232453 - long intergenic non-protein coding RNA 2777

GSE144843 GSE144844 SMARCA2 SMARCA4 knockdown 5 v 4 human up

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 4 v 1 human dn

A Gene Set from LINCS

GSE139540 menadione 4 v 1 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 7 human dn

A Gene Set from LINCS

GSE239844 crizotinib 4 v 5 human up

A Gene Set from LINCS

GSE89484 GSE89669 demethylase inhibition Novikoff-Hepatoma 0 v 1 human dn

A Gene Set from LINCS

GSE184892 trehalose fibroblast 0 v 2 human up

A Gene Set from LINCS

GSE112202 digoxin 4 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.